Category: Company — company milestones, exhibitions, and technology highlights from BBT Medical.
BBT CEO Qiu Xuewen met Nami Surgical COO Nico Fenu to discuss miniaturized ultrasonic technology for wristed robotic platforms and toured BBT's R&D and manufacturing facilities.
Hunan Medical Insurance Bureau confirms July 1 execution of the 29-province electrosurgery VBP. BBT Likashow portfolio won selection across five product groups.
Tianjin's procurement center launched price linkage confirmation for the 3+N alliance covering spring coils, endoscopic staplers, and biochemistry reagents through June 16.
Anhui's volume-based linkage data window for trocars and staplers runs through June 12. BBT invites nationwide partners to collaborate on listing and market expansion.
Global ultrasonic scalpel market reached $2.92B in 2025 and is projected to hit $3.94B by 2030. VBP policies and domestic innovation are accelerating Chinese brand penetration.
Hunan-led 29-province electrosurgery VBP secondary volume rules eliminate non-selected brands, cut revived selections by 50%, and block price-corrected products from incremental pools.
BBT highlights electric endoscopic linear staplers for the Beijing-Tianjin-Hebei 3+N alliance and fully selected electrosurgery lines for the 29-province VBP secondary volume window.
On April 9, the 93rd China International Medical Equipment Fair (CMEF), the "vane" of the global medical and health industry, opened grandly in Shanghai. Wuhan Half the Sky Medical Technology Development Co., Ltd. made…
On March 27, the 41st China (Wuhan) Medical Equipment Exhibition opened grandly at the Wuhan International Convention and Exhibition Center. As the oldest and most influential medical and health industry event in…
On March 27, the Hainan Free Trade Port Policy Publicity and Promotion Conference (Wuhan), "Eqiong joins hands to create new overseas opportunities", was held at Hubei Liantou East Lake High-tech Group. Qiu Xuewen,…
